Patents
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
12/2002
12/11/2002EP1100805B1 Medicine nitrate salts
12/11/2002EP0937064B1 Substituted oximes derivatives useful as neurokinin antagonists
12/11/2002EP0923568B1 Novel benzofuran-4-carboxamides
12/11/2002EP0920456B1 Phosgenated oxime resins and their preparation
12/11/2002EP0873337B1 Salts of n-(4-oxo-2-(1h-tetrazoyl-5-yl)-4h-1-benzopyran-8-yl)-4-(4-phenylbutoxy)benzamide
12/11/2002EP0863891B1 (methylsulfonyl)phenyl-2-(5h)-furanones as cox-2 inhibitors
12/11/2002EP0837854B1 Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
12/11/2002EP0805796B1 Cell adhesion inhibitors
12/11/2002EP0662958B1 1-(2-oxo-acetyl)-piperidine-2-carboxylic acid derivatives as multi-drug-resistent cancer cell sensitizers
12/11/2002CN1384825A Benzylidene thiazolidiones and analogues and their use in treatment of inflammation
12/11/2002CN1384100A Benzo-1,3-dioxole and benzofuran substituted pentazane derivative
12/11/2002CN1095837C Pyridazinone and application as fungicide
12/11/2002CA2411165A1 Novel indole derivatives exhibiting chymase-inhibitory activities and process for preparation thereof
12/10/2002USRE37936 Pesticidal 1-polyarylpyrazoles
12/10/2002US6492553 A method for preparing a n-((aliphatic or aromatic)carbonyl) )-2-aminoacetamide compound, and for preparing a cyclized compound therefrom, as well as novel resin bound intermediate compounds that are useful for preparing such compounds.
12/10/2002US6492529 Bis pyrazole-1H-pyrazole intermediates and their synthesis
12/10/2002US6492422 Tricyclic sulfonamides and their derivatives as inhibitors of matrix metalloproteinases
12/10/2002US6492416 4,5-diaryl-3(2H)-furanone derivatives as cyclooxygenase-2 inhibitors
12/10/2002US6492411 Substituted pyrazolyl benzenesulfonamides for the treatment of inflammation
12/10/2002US6492401 Sodium hydrogen exchanger type 1 inhibitors; reducing perioperative myocardial tissue damage
12/10/2002US6492400 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
12/10/2002US6492393 Compounds useful as anti-inflammatory agents
12/10/2002US6492392 2-piperidone compounds
12/10/2002US6492390 Treating cyclooxygenase-2 mediated disorders.
12/10/2002US6492376 Polyhydroxylated monocyclic N-heterocyclic derivatives as anti-coagulants
12/10/2002US6492374 Benzofuran derivatives, their preparation and use
12/10/2002US6492372 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
12/10/2002US6492367 Sulfamato hydroxamic acid metalloprotease inhibitor
12/10/2002US6492366 Cyano-indole serotonin-reuptake inhibitor compound
12/10/2002US6492365 Microsomal triglyceride transfer protein
12/10/2002US6492360 Phthalazine derivatives phosphodiesterase 4 inhibitors
12/10/2002US6491989 Fluorinated naphthalene derivatives and their use in liquid crystal mixtures
12/10/2002US6491187 Inverted aerosol dispenser
12/10/2002CA2230445C Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
12/05/2002WO2002096910A1 Cytotoxins, prodrugs, linkers and stabilizers useful therefor
12/05/2002WO2002096905A1 Thiazole compounds useful as inhibitors of protein kinases
12/05/2002WO2002096902A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/05/2002WO2002096889A1 Quinazolinone compound and method of preparation and use thereof in preparing anticancerous medicament
12/05/2002WO2002096888A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002WO2002096887A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002WO2002096886A1 Pyrimidine derivatives
12/05/2002WO2002096879A1 Aminoquinoline and aminopyridine derivatives and their use as adenosine a3 ligands
12/05/2002WO2002096876A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002WO2002096867A2 Inhibitors of protein kinase for the treatment of disease
12/05/2002WO2002096426A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002WO2002096362A2 Method for treating fibrotic diseases or other indications vi
12/05/2002WO2002096361A2 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
12/05/2002WO2002096359A2 Piperazine pentanamide hiv protease inhibitors
12/05/2002WO2002096317A2 Method for treating glaucoma vi
12/05/2002WO2002078693A3 N-(2-arylethyl)benzylamines as antagonists of the 5-ht6 receptor
12/05/2002WO2002074036A3 Substituted benzopyranones as telomerase inhibitors
12/05/2002WO2002059116A3 Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
12/05/2002US20020183502 Oligonucleotides for use in the human therapeutics and diagnostics
12/05/2002US20020183378 Novel crystal forms of atorvastatin hemi-calcium and processes for their preparation as well as novel processes for preparing other forms
12/05/2002US20020183370 3-(cycloalkanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors
12/05/2002US20020183364 Methods of modulating protein tyrosine kinase function with substituted indolinone compounds
12/05/2002US20020183335 2, 4-disubstituted pyrimidine-5-carboxamide derivatives as KCNQ potassium channel modulators
12/05/2002US20020183325 Phthalazinone derivatives
12/05/2002US20020183323 For therpay of inflammatory bowel disease, cerebral ischemia and arthritis, adult respiratory distress syndrome (ARDS) and myocarditis, as adjuvants to short term immunosuppression in transplant therapy
12/05/2002US20020183318 Novel derivatives of flavones, xanthones and coumarins
12/05/2002US20020183316 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
12/05/2002US20020183309 For therapy of acute myocardial infarction, asthma, bipolar disorder, cognitive enhancement, cognitive deficits in psychiatric disorders, cutaneous carcinoma, drug abuse, depression, gastrointestinal disorders, inflammation
12/05/2002CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002CA2448626A1 Carbamate and oxamide compounds as inhibitors of cytokine production
12/05/2002CA2448305A1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
12/05/2002CA2448294A1 Method for treating fibrotic diseases or other indications vi
12/05/2002CA2448276A1 Method for treating glaucoma vi
12/05/2002CA2447475A1 Hydantion derivatives as inhibitors of matrix metalloproteinases
12/05/2002CA2447234A1 Carbazole derivatives and their use for the preparation of pharmaceutical compositions for the treatment of npy related diseases
12/04/2002EP1262475A1 Indole derivatives, process for preparation of the same and use thereof
12/04/2002EP1261603A1 Flavone derivatives, preparation method and use as medicines
12/04/2002EP1261588A1 New imidazole derivatives
12/04/2002EP1261585A1 Substituted indole mannich bases
12/04/2002EP1261327A2 Adenosine receptor modulators
12/04/2002EP1261321A2 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
12/04/2002EP1077967B1 Biphenyl oxo-acetic acids useful in the treatment of insulin resistance and hyperglycemia
12/04/2002EP1022277B1 New taxane derivatives
12/04/2002EP1001930B1 N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases
12/04/2002EP0912561B1 3-phenyl-furan-(5h)-2-one and dihydrofuran-2-one derivatives as antibacterial agents
12/04/2002CN1383424A Aryl and heteroacrylcyclopropyl oxime ethers and their use as fungicides
12/04/2002CN1382688A Chromone compounds with antineoplastic activity and its open-loop products and preparing process
12/04/2002CN1382442A Method for preventing dyskinesia
12/03/2002US6489364 From l-mannonic-gamma-lactone intermediates; for prophylaxis of hiv/aids hiv
12/03/2002US6489354 In particular, these compounds are useful as modulators of the chemokine receptors ccr-3 and/or ccr-5 useful in the treatment and prevention of atopic conditions including allergic rhinitis, dermatitis, conjunctivitis, and asthma
12/03/2002US6489347 Process
12/03/2002US6489344 For treatment diabetes in a human or animal subject
12/03/2002US6489343 Tetrahydropyran derivatives and their use as therapeutic agents
12/03/2002US6489324 Piperazine compounds as inhibitors of MMP or TNF
12/03/2002US6489314 Due to the increasing interest in epothilones as anti-cancer agents, novel derivatives of these compounds are needed and desired to more fully develop their therapeutic potential
12/03/2002CA2216617C New flavone derivatives, their preparation procedures and the pharmaceutical compositions containing them
12/03/2002CA2030689C Barbiturate assay compositions and methods
11/2002
11/28/2002WO2002094820A1 Crystalline salts of 2-(4-{2-[2-hydroxy-3-(2-thiophen-2-yl-phenoxy)-propylamino]-2-methyl-propyl}-phenoxy)-nicotinonitrile
11/28/2002WO2002094818A1 Method for the production of triazolylmethylepoxides
11/28/2002WO2002094812A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094811A1 4-(penyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094810A1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
11/28/2002WO2002094809A1 3-quinoline-2-(1h)-ylideneindolin-2-one derivatives
11/28/2002WO2002094796A2 Benzo[g]quinoxaline derivatives as effective compounds against infectious diseases
11/28/2002WO2002094795A1 4-aminopyrimidine derivatives
11/28/2002WO2002094793A1 Acylated 4-aminopyrazoles